Showing results (31-40 of 148) with videos related to
Sort By:
Pageof 15
Scottish Medical Journal|July 1, 1982
Does hypothyroidism predispose to gold-induced thrombocytopenia?J A Hunter, H A CapellBritish Journal of Rheumatology|June 1, 1993
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placeboD R Porter, H A CapellBailliere'S Clinical Rheumatology|December 1, 1990
The use of sulphasalazine as a disease modifying antirheumatic drugD R Porter, H A CapellBritish Journal of Rheumatology|July 1, 1992
Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugsE A Kay, T PullarRheumatology (Oxford, England)|July 2, 2003
Attitude of rheumatoid arthritis patients to treatment with oral corticosteroidsE Morrison, D Crosbie, H A CapellAnnals of the Rheumatic Diseases|September 1, 1986
A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritisH A Capell, D Lewis, J CareyBritish Journal of Rheumatology|October 1, 1991
Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugsM Brzeski, R Madhok, H A CapellAnnals of the Rheumatic Diseases|October 1, 1989
Compliance in clinical trialsT Pullar, S Kumar, M FeelyScandinavian Journal of Rheumatology|April 25, 2000
Acute non-purulent inflammatory arthropathy associated with Staphylococcus aureus abscessA W Al-Allaf, T PullarBritish Journal of Rheumatology|June 1, 1990
What do patients and rheumatologists regard as an 'acceptable' risk in the treatment of rheumatic disease?T Pullar, V Wright, M FeelyPageof 15